Five key findings:
1. In 2020 there were 380 private equity deals in healthcare across the globe, a 21 percent increase from the 313 recorded in 2019. These record-setting numbers come even as private equity deal activity across all sectors fell 14 percent in 2020.
2. The disclosed value of healthcare private equity deals fell 17 percent to $66 billion last year.
3. Globally, the healthcare provider and biopharma sectors were the most active for private equity deals, with nearly 150 deals in each sector.
4. In North America specifically, healthcare private equity deal volume dropped to 142 deals last year, compared to 159 in 2019. Disclosed deal values also dropped to $34.7 billion, down from $46.7 billion announced in 2019.
5. The average deal value in North America dropped significantly, to $500 million, in 2020, down from about $1 billion in 2019. This is due to a decline in large healthcare deals.
Access the full report here.
More articles on healthcare industry transactions:
Insight Chicago would buy Mercy Hospital for $1, change its name
OSF HealthCare to acquire majority stake in Kindred hospital, rename it
US settles antitrust case against Geisinger, Evangelical
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
